View in EDS

MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).

Saved in:
Bibliographic Details
Title: MIRACLE-UC: Mirikizumab Investigation of Real-world Assessment of Clinical and Long-term Effectiveness and Adverse Events in Patients with Ulcerative Colitis - A Multicenter Prospective Study from the Italian Group for the Study of Inflammatory Bowel Diseases (IG-IBD).
Authors: Barberio, B.1, Todeschini, A.2, Laterza, L.3, Viola, A.4, Bezzio, C.5, Mendolaro, M.6, Caprioli, F.7, Saibeni, S.8, Gerardi, V.9, Marafini, I.10, Ribaldone, D. G.11, M Onico, M. C.12, Viganò, C.13, Cappello, M.14, Dragoni, G.15, Gravina, A. G.16, Miranda, A.17, Mocci, G.18, Felice, C.19, Principi, M. B.20
Source: Journal of Crohn's & Colitis. 2026 Supplement, Vol. 20, pi1625-i1628. 4p.
Database: Academic Search Ultimate
Description
ISSN:18739946